Pulmonary fungal infections in kidney transplant recipients: an 8-year study

F Sharifipour1, F Rezaeetalab, M Naghibi

  • 1Mashhad University of Medical Sciences, Mashhad, Iran.

Abstract

Insights

Pulmonary fungal infections (PFI) affect 2.2% of kidney transplant patients, with Aspergillus being the most common cause. Immunosuppression and broad-spectrum antibiotics are key risk factors for these life-threatening infections.

Area of Science:

  • Medical Mycology
  • Transplant Infectious Diseases
  • Critical Care Medicine

Background:

  • Invasive fungal infections (IFIs) are a significant cause of mortality in transplant recipients.
  • Pulmonary fungal infection (PFI) is a common and serious manifestation of IFIs.

Purpose of the Study:

  • To determine the incidence rate of PFI in kidney transplant recipients.
  • To identify common fungal pathogens and risk factors associated with PFI in this population.

Main Methods:

  • Retrospective analysis of 595 kidney transplant patients from February 1999 to February 2007.
  • Confirmation of PFI using bronchoalveolar lavage (BAL) cultures and tissue biopsies.

Main Results:

  • The incidence of PFI was 2.2% (13 out of 595 patients).
  • Aspergillus was the most frequent pathogen (41.5%), followed by Candida and mucormycosis in co-infections.
  • Mortality was high (53.8%), with 30.7% experiencing graft loss. Immunosuppressive therapy and broad-spectrum antibiotics were identified as major risk factors.

Conclusions:

  • PFI is a critical complication in kidney transplant patients, contributing significantly to mortality.
  • Aspergillus species are the predominant pathogens causing PFI.
  • Immunosuppressive therapy and broad-spectrum antibiotic use are crucial modifiable risk factors that warrant careful management.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...